ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 88 filers reported holding ANTARES PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $90,000 | +80.0% | 38,641 | +28.8% | 0.00% | – |
Q3 2016 | $50,000 | +78.6% | 30,001 | +11.8% | 0.00% | – |
Q2 2016 | $28,000 | -99.2% | 26,842 | -99.3% | 0.00% | -100.0% |
Q1 2016 | $3,499,000 | -29.6% | 4,021,172 | -2.1% | 0.00% | 0.0% |
Q4 2015 | $4,970,000 | -27.4% | 4,107,485 | +1.9% | 0.00% | -50.0% |
Q3 2015 | $6,850,000 | -16.8% | 4,029,311 | +1.7% | 0.00% | 0.0% |
Q2 2015 | $8,237,000 | -8.1% | 3,960,332 | +19.7% | 0.00% | 0.0% |
Q1 2015 | $8,965,000 | +7.5% | 3,307,971 | +2.0% | 0.00% | 0.0% |
Q4 2014 | $8,337,000 | +61.9% | 3,243,777 | +15.3% | 0.00% | +100.0% |
Q3 2014 | $5,150,000 | -33.5% | 2,813,980 | -2.9% | 0.00% | -50.0% |
Q2 2014 | $7,741,000 | -30.3% | 2,899,286 | -8.6% | 0.00% | -33.3% |
Q1 2014 | $11,105,000 | -19.3% | 3,172,823 | +3.1% | 0.00% | -25.0% |
Q4 2013 | $13,763,000 | +6.2% | 3,078,300 | -3.6% | 0.00% | 0.0% |
Q3 2013 | $12,963,000 | +10.9% | 3,192,935 | +13.6% | 0.00% | 0.0% |
Q2 2013 | $11,690,000 | – | 2,810,021 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |